Cargando…

Modeling the potential efficiency of a blood biomarker-based tool to guide pre-hospital thrombolytic therapy in stroke patients

OBJECTIVES: Stroke treatment with intravenous tissue-type plasminogen activator (tPA) is effective and efficient, but as its benefits are highly time dependent, it is essential to treat the patient promptly after symptom onset. This study evaluates the cost-effectiveness of a blood biomarker test to...

Descripción completa

Detalles Bibliográficos
Autores principales:	Parody-Rua, Elizabeth, Bustamante, Alejandro, Montaner, Joan, Rubio-Valera, Maria, Serrano, David, Pérez-Sánchez, Soledad, Sánchez-Viñas, Alba, Guevara-Cuellar, César, Serrano-Blanco, Antoni
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2022
Materias:	Original Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10175459/ https://www.ncbi.nlm.nih.gov/pubmed/35896861 http://dx.doi.org/10.1007/s10198-022-01495-1

Ejemplares similares

Economic Evaluations Informed Exclusively by Real World Data: A Systematic Review
por: Parody-Rúa, Elizabeth, et al.
Publicado: (2020)

Cost-effectiveness analysis of nonoperative management versus open and laparoscopic surgery for uncomplicated acute appendicitis in Colombia
por: Guevara-Cuellar, César Augusto, et al.
Publicado: (2021)

Cost-effectiveness analysis of a multiple health behaviour change intervention in people aged between 45 and 75 years: a cluster randomized controlled trial in primary care (EIRA study)
por: Aznar-Lou, Ignacio, et al.
Publicado: (2021)

Review of Stroke Thrombolytics
por: Bivard, Andrew, et al.
Publicado: (2013)

Effectiveness and cost-effectiveness of an intervention to improve Initial Medication Adherence to treatments for cardiovascular diseases and diabetes in primary care: study protocol for a pragmatic cluster randomised controlled trial and economic model (the IMA-cRCT study)
por: Sánchez-Viñas, Alba, et al.
Publicado: (2022)

Evaluation of pre-hospital transport time of stroke patients to thrombolytic treatment
por: Simonsen, Sofie Amalie, et al.
Publicado: (2014)

Stroke-induced immunosuppression: implications for the prevention and prediction of post-stroke infections
por: Faura, Júlia, et al.
Publicado: (2021)

Development and Testing of Thrombolytics in Stroke
por: Nikitin, Dmitri, et al.
Publicado: (2021)

Improving Initial Medication Adherence to cardiovascular disease and diabetes treatments in primary care: Pilot trial of a complex intervention
por: Corral-Partearroyo, Carmen, et al.
Publicado: (2022)

CT-guided thrombolytic treatment of patients with wake-up strokes()
por: Armon, Carmel, et al.
Publicado: (2019)

Initiation and Single Dispensing in Cardiovascular and Insulin Medications: Prevalence and Explanatory Factors
por: Vilaplana-Carnerero, Carles, et al.
Publicado: (2020)

Thrombolytic Therapy for Acute Stroke: The Hidden Dimension
por: Mansour, Ossama, et al.
Publicado: (2010)

Intravenous Thrombolytics in the Treatment of Acute Ischemic Stroke
por: Alhadid, Kenda, et al.
Publicado: (2023)

Attitudes and intended behaviour to mental disorders and associated factors in catalan population, Spain: cross-sectional population-based survey
por: Aznar-Lou, Ignacio, et al.
Publicado: (2016)

Evaluation and Characterization of Post-Stroke Lung Damage in a Murine Model of Cerebral Ischemia
por: Faura, Júlia, et al.
Publicado: (2022)

Cardioembolic Stroke Diagnosis Using Blood Biomarkers
por: Llombart, VÍctor, et al.
Publicado: (2013)

Pre- and in-hospital delays in the use of thrombolytic therapy for patients with acute ischemic stroke in rural and urban Egypt
por: Nasreldein, Ahmed, et al.
Publicado: (2023)

Predictive role of pre-thrombolytic hs-CRP on the safety and efficacy of intravenous thrombolysis in acute ischemic stroke
por: Cheng, Xu-Dong, et al.
Publicado: (2023)

Inflammatory and stress markers predicting pneumonia, outcome, and etiology in patients with stroke: Biomarkers for predicting pneumonia, functional outcome, and death after stroke
por: Hotter, Benjamin, et al.
Publicado: (2020)

Evolution of the Thrombolytic Treatment Window for Acute Ischemic Stroke
por: Stemer, Andrew, et al.
Publicado: (2010)

Computational Simulations of Thrombolytic Therapy in Acute Ischaemic Stroke
por: Piebalgs, Andris, et al.
Publicado: (2018)

Chest Computed Tomography Findings and Validation of Clinical Criteria of Stroke Associated Pneumonia
por: Zapata-Arriaza, Elena, et al.
Publicado: (2019)

Strategies to Extend Thrombolytic Time Window for Ischemic Stroke Treatment: An Unmet Clinical Need
por: Peña, Ike dela, et al.
Publicado: (2017)

Selection bias in clinical stroke trials depending on ability to consent
por: Hotter, Benjamin, et al.
Publicado: (2017)

Biomarkers predictive value for early diagnosis of Stroke‐Associated Pneumonia
por: Zapata‐Arriaza, Elena, et al.
Publicado: (2019)

Community pharmacist intervention in depressed primary care patients (PRODEFAR study): randomized controlled trial protocol
por: Rubio-Valera, Maria, et al.
Publicado: (2009)

Health service use and costs associated with aggressiveness or agitation and containment in adult psychiatric care: a systematic review of the evidence
por: Rubio-Valera, Maria, et al.
Publicado: (2015)

Gender Gap in the Leadership of Health Institutions: The Influence of Hospital-Level Factors
por: Pérez-Sánchez, Soledad, et al.
Publicado: (2021)

Acute Thrombolytic Therapy Combined with the Green Channel Can Reduce the Thrombolytic Time and Improve Neurological Function in Acute Stroke Patients
por: Hong, Zhen, et al.
Publicado: (2022)

Thrombolytic or endovascular therapy for acute ischemic stroke: Time is brain
por: Mijajlovic, Milija D.
Publicado: (2014)

Repeated Thrombolytic Therapy in Patients with Recurrent Acute Ischemic Stroke
por: Yoo, Han Soo, et al.
Publicado: (2013)

Susceptibility-weighted Imaging in Thrombolytic Therapy of Acute Ischemic Stroke
por: Li, Lin, et al.
Publicado: (2017)

Temperature-Induced Changes in Reperfused Stroke: Inflammatory and Thrombolytic Biomarkers
por: Ávila-Gómez, Paulo, et al.
Publicado: (2020)

Cholesterol reducer and thrombolytic therapy in acute ischemic stroke patients
por: Poupore, Nicolas, et al.
Publicado: (2020)

Retracted: Acute Thrombolytic Therapy Combined with the Green Channel Can Reduce the Thrombolytic Time and Improve Neurological Function in Acute Stroke Patients
por: and Alternative Medicine, Evidence-Based Complementary
Publicado: (2023)

The Usefulness of the Kurashiki Prehospital Stroke Scale in Identifying Thrombolytic Candidates in Acute Ischemic Stroke
por: Jang, Jieun, et al.
Publicado: (2014)

Impacto de una intervención farmacéutica en la prevención de recaídas en depresión en atención primaria()
por: Rubio-Valera, María, et al.
Publicado: (2016)

Pharmaceutical Sponsorship Bias Influences Thrombolytic Literature in Acute Ischemic Stroke
por: Radecki, Ryan Patrick
Publicado: (2011)

Effectiveness of Thrombolytic Therapy in Acute Embolic Stroke due to Infective Endocarditis
por: Sontineni, Siva P., et al.
Publicado: (2009)

Effects of Nursing Quality Improvement on Thrombolytic Therapy for Acute Ischemic Stroke
por: Liu, Zhuo, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_2epp87ml5bm750rdne8lrj0u5l